IRST Meldola

Meldola (FC) 47014

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Cancer

Studies at this site

• Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed